Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 1/20 | 0.34 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23401809 | 0.89 | FFAR1 (0.33) | ADORA2AADORA2BPOLBESR1 | |
| SCHEMBL23398864 | 0.89 | NR1H3 (0.37) | POLBESR1 | |
| SCHEMBL23399635 | 0.86 | LMNA (0.34) | — | |
| SCHEMBL23401073 | 0.86 | ADORA2A (0.35) | ADORA2AADORA2BPOLBESR1 | |
| SCHEMBL23399061 | 0.82 | ADORA2A (0.32) | ADORA2AADORA2BESR1SMN1; SMN2USP2 | |
| SCHEMBL23403591 | 0.81 | NR1H3 (0.37) | POLBESR1 | |
| SCHEMBL23401491 | 0.80 | APAF1 (0.33) | SMN1; SMN2 | |
| SCHEMBL23400442 | 0.80 | KDM4E (0.35) | ADORA2AADORA2BPOLBUSP2 | |
| SCHEMBL23400716 | 0.80 | SMN1; SMN2 (0.38) | POLBSMN1; SMN2 | |
| SCHEMBL23398762 | 0.78 | ADORA2A (0.46) | ADORA2AADORA2BPOLBESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240208911-A1 | POLYMERIZATION INHIBITORS | BASF SE (DE) | 2024-06-27 | — | — | US | disclosed |
| EP-4326783-A1 | POLYMERIZATION INHIBITORS | BASF SE (DE) | 2024-02-28 | — | — | EP | disclosed |
| CN-117222675-A | polymerization inhibitor | 巴斯夫欧洲公司 | 2023-12-12 | — | — | CN | disclosed |
| WO-2022223336-A1 | POLYMERIZATION INHIBITORS | BASF SE (DE) | 2022-10-27 | — | — | WO | disclosed |
| EP-3828159-A1 | STORAGE AND TRANSPORT STABILIZERS FOR POLYMERIZABLE COMPOUNDS | BASF SE (DE) | 2021-06-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240208911-A1 | POLYMERIZATION INHIBITORS | CDK5, CABLES1, DPYD | ADORA2A 4815/4885ADORA2B 4472/4885POLB 606/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.